Connect Biopharma Holdings (CNTB) Prepaid Assets (2020 - 2026)
Connect Biopharma Holdings (CNTB) posted quarterly Prepaid Assets of $9.0 million for Q1 2026, up 139.5% year-on-year from $3.8 million in Q1 2025, and up 36.69% on a QoQ basis from $6.6 million in Q4 2025.
Connect Biopharma Holdings (CNTB) Prepaid Assets (2020 - 2026) Analysis & Trends
Connect Biopharma Holdings (CNTB) has reported Prepaid Assets for 7 consecutive years, with $9.0 million the latest figure, recorded in Q1 2026.
- Quarterly Prepaid Assets rose 139.5% year-over-year to $9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.0 million (up 139.5% YoY) and the FY2025 annual result came in at $6.6 million, up 166.8% from the prior year.
- Prepaid Assets advanced to $9.0 million in Q1 2026 per CNTB's latest filing, from $6.6 million in the prior quarter.
- Over the last five years, Prepaid Assets for CNTB reached as high as $9.0 million in Q1 2026 and fell as low as $2.2 million in Q2 2024.
- A 5-year average of $4.7 million and a median of $4.2 million in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets slumped 54.0% — and 2025, when it surged 176.84%.
- Year by year, Prepaid Assets stood at $2.7 million in 2022, then jumped by 60.18% to $4.2 million in 2023, then slumped by 42.02% to $2.5 million in 2024, then jumped by 166.8% to $6.6 million in 2025, then surged by 36.69% to $9.0 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $9.0 million, $6.6 million, and $7.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Connect Biopharma Holdings | 120.44 Mn | 120.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.99 Mn |
| Dec 31, 2025 | 6.57 Mn |
| Sep 30, 2025 | 7.80 Mn |
| Jun 30, 2025 | 5.99 Mn |
| Mar 31, 2025 | 3.75 Mn |
| Dec 31, 2024 | 2.46 Mn |
| Jun 30, 2024 | 2.16 Mn |
| Dec 31, 2023 | 4.25 Mn |
| Jun 30, 2023 | 2.36 Mn |
| Dec 31, 2022 | 2.65 Mn |
| Jun 30, 2022 | 4.60 Mn |
| Dec 31, 2021 | 5.77 Mn |
| Dec 31, 2020 | 4.23 Mn |